• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房收治的急性肾损伤患者行持续肾脏替代治疗(CRRT)时的枸橼酸盐抗凝。

Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit.

作者信息

Davenport Andrew, Tolwani Ashita

机构信息

UCL Center for Nephrology, Royal Free Campus , University College London Medical School , London , UK.

Division of Nephrology , University of Alabama at Birmingham , Birmingham, AL , USA.

出版信息

NDT Plus. 2009 Dec;2(6):439-47. doi: 10.1093/ndtplus/sfp136. Epub 2009 Sep 25.

DOI:10.1093/ndtplus/sfp136
PMID:25949376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4421325/
Abstract

Continuous forms of renal replacement therapy (CRRT) have become established as the treatment of choice for supporting critically ill patients with acute kidney injury. Typically, these patients have activation of the coagulation cascades, peripheral mononuclear cells and platelets, but also a reduction in natural anticoagulants, and are therefore prothrombotic. For continuous modes of renal replacement therapy to be effective, in terms of both effective solute clearance and also fluid removal, the extracorporeal circuits must operate continuously. Thus, preventing clotting in the CRRT circuit is a key goal to effective patient management. As these patients may also be at increased risk of bleeding, regional anticoagulation with citrate is increasing in popularity, particularly following the introduction of commercially available CRRT machines and fluids specifically designed for citrate anticoagulation. Although regional anticoagulation with citrate provides many advantages over other systemic anticoagulants, excess citrate may lead to both metabolic complications, ranging from acidosis to alkalosis and may also potentially expose patients to electrolyte disturbances due to hyper- and hyponatraemia and hyper- and hypocalcaemia.

摘要

连续性肾脏替代治疗(CRRT)已成为治疗急性肾损伤危重症患者的首选方法。通常,这些患者的凝血级联反应、外周单核细胞和血小板被激活,同时天然抗凝物质减少,因此处于血栓形成前状态。为使连续性肾脏替代治疗有效,无论是在有效清除溶质还是在清除液体方面,体外循环都必须持续运行。因此,防止CRRT回路凝血是有效管理患者的关键目标。由于这些患者出血风险也可能增加,枸橼酸盐局部抗凝越来越受欢迎,尤其是在市售的专门为枸橼酸盐抗凝设计的CRRT机器和液体推出之后。尽管枸橼酸盐局部抗凝比其他全身抗凝剂具有许多优势,但过量的枸橼酸盐可能导致从酸中毒到碱中毒的各种代谢并发症,还可能因高钠血症、低钠血症、高钙血症和低钙血症而使患者面临电解质紊乱的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/1c15324e91c4/sfp136fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/97cd2e0dc6b7/sfp136fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/d1f8456abb45/sfp136fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/91720c83f610/sfp136fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/c55f945362cf/sfp136fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/1c15324e91c4/sfp136fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/97cd2e0dc6b7/sfp136fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/d1f8456abb45/sfp136fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/91720c83f610/sfp136fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/c55f945362cf/sfp136fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1e4b/4421325/1c15324e91c4/sfp136fig5.jpg

相似文献

1
Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit.重症监护病房收治的急性肾损伤患者行持续肾脏替代治疗(CRRT)时的枸橼酸盐抗凝。
NDT Plus. 2009 Dec;2(6):439-47. doi: 10.1093/ndtplus/sfp136. Epub 2009 Sep 25.
2
Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.局部枸橼酸抗凝用于高出血风险外科患者的大容量连续性静脉-静脉血液透析
Ther Apher Dial. 2013 Apr;17(2):202-12. doi: 10.1111/j.1744-9987.2012.01101.x. Epub 2012 Aug 29.
3
Citrate clearance in children receiving continuous venovenous renal replacement therapy.接受持续静静脉肾脏替代治疗的儿童的枸橼酸盐清除率
Pediatr Nephrol. 2002 Oct;17(10):819-24. doi: 10.1007/s00467-002-0963-6. Epub 2002 Sep 7.
4
Renal replacement therapy and anticoagulation.肾脏替代治疗与抗凝。
Best Pract Res Clin Anaesthesiol. 2017 Sep;31(3):387-401. doi: 10.1016/j.bpa.2017.08.005. Epub 2017 Aug 24.
5
Effects of regional citrate anticoagulation on thrombin generation, fibrinolysis and platelet function in critically ill patients receiving continuous renal replacement therapy for acute kidney injury: a prospective study.局部枸橼酸盐抗凝对急性肾损伤接受连续性肾脏替代治疗的危重症患者凝血酶生成、纤维蛋白溶解及血小板功能的影响:一项前瞻性研究。
Ann Intensive Care. 2022 Mar 31;12(1):29. doi: 10.1186/s13613-022-01004-w.
6
[Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].[肝切除术后急性肾损伤患者连续性肾脏替代治疗中局部枸橼酸抗凝的安全性与有效性]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Aug;30(8):777-782. doi: 10.3760/cma.j.issn.2095-4352.2018.08.013.
7
The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.局部枸橼酸盐抗凝对急性肾损伤接受连续性肾脏替代治疗的危重症患者凝血系统的影响——一项观察性队列研究
BMC Nephrol. 2017 Oct 2;18(1):304. doi: 10.1186/s12882-017-0718-z.
8
Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.柠檬酸盐与肝素抗凝在小儿连续性肾脏替代治疗中的比较。
Pediatr Nephrol. 2017 Oct;32(10):1971-1978. doi: 10.1007/s00467-017-3694-4. Epub 2017 Jun 4.
9
[Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].连续性肾脏替代治疗(CRRT)仍将是危重症患者中应用最广泛的透析方式。
G Ital Nefrol. 2009 Jan-Feb;26(1):13-21.
10
Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.用于PrismaFlex持续肾脏替代治疗的局部枸橼酸盐抗凝法。
Ann Pharmacother. 2009 Sep;43(9):1419-25. doi: 10.1345/aph.1M182. Epub 2009 Aug 18.

引用本文的文献

1
Regional Citrate Anticoagulation Versus Systemic Heparin in Continuous Kidney Replacement Therapy: Examining the Role of Evidence in Health Technology Assessment.连续性肾脏替代治疗中局部枸橼酸抗凝与全身肝素抗凝的比较:探讨证据在卫生技术评估中的作用
Adv Ther. 2025 Jun;42(6):2606-2638. doi: 10.1007/s12325-025-03186-8. Epub 2025 Apr 16.
2
Net buffer load during regional citrate anticoagulated continuous renal replacement therapy.局部枸橼酸盐抗凝持续肾脏替代治疗期间的净缓冲液负荷
PLoS One. 2025 Jan 30;20(1):e0315727. doi: 10.1371/journal.pone.0315727. eCollection 2025.
3
Optimizing Continuous Renal Replacement Therapy with Regional Citrate Anticoagulation: Insights from the ORCA Trial-A Retrospective Study on 10 Years of Practice.

本文引用的文献

1
Management of Heparin-Induced Thrombocytopenia During Renal Replacement Therapy.肾脏替代治疗期间肝素诱导的血小板减少症的管理
Hemodial Int. 2001 Jan;5(1):81-85. doi: 10.1111/hdi.2001.5.1.81.
2
Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.抗肝素-血小板因子4复合物抗体:血液透析中肝素诱导的血小板减少症的发病机制、流行病学及管理
Am J Kidney Dis. 2009 Aug;54(2):361-74. doi: 10.1053/j.ajkd.2009.03.012. Epub 2009 May 29.
3
Citrate anticoagulation for continuous venovenous hemofiltration.
优化局部枸橼酸抗凝的连续性肾脏替代治疗:来自ORCA试验的见解——一项基于10年实践的回顾性研究
Life (Basel). 2024 Oct 14;14(10):1304. doi: 10.3390/life14101304.
4
Hyponatremia in Critically Ill Patients Due to Continuous Venovenous Hemofiltration With Diluted Sodium Citrate.使用稀释枸橼酸钠进行持续静脉-静脉血液滤过导致危重症患者低钠血症
ASAIO J. 2025 Apr 1;71(4):355-362. doi: 10.1097/MAT.0000000000002330. Epub 2024 Oct 22.
5
An Overview of Pre-Analytical Factors Impacting Metabolomics Analyses of Blood Samples.影响血样代谢组学分析的分析前因素概述。
Metabolites. 2024 Aug 28;14(9):474. doi: 10.3390/metabo14090474.
6
Citrate Promotes Nitric Oxide Production during Human Sperm Capacitation.柠檬酸盐在人类精子获能过程中促进一氧化氮生成。
Antioxidants (Basel). 2024 Jul 23;13(8):885. doi: 10.3390/antiox13080885.
7
Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children.危重症儿童连续性肾脏替代治疗中柠檬酸盐抗凝与全身肝素抗凝。
Pediatr Res. 2024 Aug;96(3):702-712. doi: 10.1038/s41390-024-03163-x. Epub 2024 Mar 30.
8
Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States.连续肾脏替代治疗的抗凝实践:来自美国医生的调查。
Ren Fail. 2023;45(2):2290932. doi: 10.1080/0886022X.2023.2290932. Epub 2023 Dec 11.
9
Hypercitratemia is a mortality predictor among patients on continuous venovenous hemodiafiltration and regional citrate anticoagulation.高柠檬酸血症是连续性静脉-静脉血液透析滤过和局部枸橼酸抗凝患者的死亡预测因子。
Sci Rep. 2023 Nov 17;13(1):20176. doi: 10.1038/s41598-023-47644-1.
10
Clinical Trial Comparing the Efficacy and Safety of Regional Citrate Anticoagulation Versus Heparin in CRRT.比较局部枸橼酸抗凝与肝素在连续性肾脏替代治疗中的疗效和安全性的临床试验。
Indian J Nephrol. 2023 Jul-Aug;33(4):254-258. doi: 10.4103/ijn.ijn_169_22. Epub 2023 Mar 7.
用于连续性静脉-静脉血液滤过的枸橼酸盐抗凝法。
Crit Care Med. 2009 Feb;37(2):545-52. doi: 10.1097/CCM.0b013e3181953c5e.
4
Continuous veno-venous hemofiltration with regional citrate anticoagulation: a four-year single-center experience.持续静脉-静脉血液滤过联合局部枸橼酸盐抗凝:一项为期四年的单中心经验
Int J Artif Organs. 2008 Nov;31(11):937-43. doi: 10.1177/039139880803101103.
5
Parenteral calcium for intensive care unit patients.重症监护病房患者的肠外补钙
Cochrane Database Syst Rev. 2008 Oct 8(4):CD006163. doi: 10.1002/14651858.CD006163.pub2.
6
Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation.
Int J Artif Organs. 2008 Apr;31(4):363-6. doi: 10.1177/039139880803100414.
7
Citrate anticoagulation for postdilutional online hemodiafiltration with calcium-containing dialysate and infusate: significant clotting in the venous bubble trap.使用含钙透析液和输注液进行后置稀释在线血液透析滤过时的柠檬酸盐抗凝:静脉空气捕捉器中出现明显凝血。
Int J Artif Organs. 2008 Apr;31(4):323-8. doi: 10.1177/039139880803100408.
8
Volume management by renal replacement therapy in acute kidney injury.急性肾损伤中肾脏替代治疗的容量管理
Int J Artif Organs. 2008 Feb;31(2):145-55. doi: 10.1177/039139880803100207.
9
Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure.在急性肾衰竭患者中,使用目前市售的置换液替代高容量血液滤过置换对电解质平衡和酸碱状态的潜在不良影响。
Int J Artif Organs. 2008 Jan;31(1):3-5. doi: 10.1177/039139880803100102.
10
Delivery of renal replacement therapy in acute kidney injury: what are the key issues?急性肾损伤中肾脏替代治疗的实施:关键问题有哪些?
Clin J Am Soc Nephrol. 2008 May;3(3):869-75. doi: 10.2215/CJN.04821107. Epub 2008 Jan 30.